ORIGINAL RESEARCH ARTICLE
Will we have a new ending for Irvin Yalom's novel? A medical oncologist view
Received Date : 23 Feb 2016
Accepted Date : 20 Apr 2016
Nalan Akgül Babacan
Marmara University, Pendik Education and Research Hospital, Department of Medical Oncology, Istanbul, Turkey
Doi: https://doi.org/10.1016/j.jons.2016.04.007 - Article's Language: EN
Journal of Oncological Science 2 (2016) 5-6
ABSTRACT
Immuno-oncology is a very popular field of medical science right now and developments on melanoma therapy have been absolutely marvelous for medical oncologists. Following these recent improvements, I remembered Irvin Yalom's novel “Schopenhauer Cure”. Because the book was narrating a psychotherapist who died from malignant melanoma. I think after all current innovations including BRAF, MEK inhibitors, and check point inhibitors, the novels' ‘end’ would be change. It is really exciting to have scientific developments that may change the end of the story in the book even though it is published less than ten years.
Keywords: Malignant melanoma; Check point inhibitors; Immunotherapy; BRAF inhibitors